Ferrando Juan, García-García Sandra Cecilia, González-de-Cossío Ana Cecilia, Bou Lola, Navarra Esperanza
Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Int J Trichology. 2017 Oct-Dec;9(4):165-170. doi: 10.4103/ijt.ijt_27_17.
Platelet-rich plasma (PRP) has emerged as a promising treatment for androgenetic alopecia (AGA). In spite of the several studies previously reported, to date, a standardized protocol for PRP preparation and application, as well as a standard method for evaluating results has not been established.
The aim of this study is to propose a standardized method for preparation and application of PRP for male AGA (MAGA) and female AGA (FAGA) and assess its safety and efficacy as a co-adjuvant therapy.
Seventy-eight patients, 19 men and 59 women with AGA Grades II-IV in Ebling's scale, currently on treatment with topical minoxidil and/or oral finasteride for more than a year without improvement, were included in this study. PRP was prepared using a single spin method, and injected in affected areas for 3 monthly sessions, followed by 3 bimonthly sessions. A decrease of at least one grade in Ebling's scale was considered a successful result.
After the 6° session, 71.4% of MAGA and 73.4% of FAGA patients reached a successful outcome while 21.4% and 16.3%, respectively, remained without changes. Only 7.1% of MAGA and 10.2% of FAGA presented worsening of their condition.
PRP together with a periodical application protocol can be considered effective as a coadjuvant therapy in patients who no longer respond to pharmacological treatments. Ebling's scale was a practical and reliable parameter to allow a better evaluation in both MAGA and FAGA.
富血小板血浆(PRP)已成为治疗雄激素性脱发(AGA)的一种有前景的方法。尽管此前已有多项研究报道,但迄今为止,尚未建立PRP制备和应用的标准化方案,以及评估结果的标准方法。
本研究的目的是提出一种用于男性AGA(MAGA)和女性AGA(FAGA)的PRP制备和应用的标准化方法,并评估其作为辅助治疗的安全性和有效性。
本研究纳入了78例患者,其中19例男性和59例女性,其Ebling分级为II-IV级AGA,目前正在接受外用米诺地尔和/或口服非那雄胺治疗一年以上但无改善。采用单次离心法制备PRP,并在受影响区域注射,每3个月注射一次,共3次,随后每2个月注射一次,共3次。Ebling分级至少降低一级被认为是成功的结果。
在第6次注射后,71.4%的MAGA患者和73.4%的FAGA患者取得了成功的结果,而分别有21.4%和16.3%的患者没有变化。只有7.1%的MAGA患者和10.2%的FAGA患者病情恶化。
PRP联合定期应用方案可被认为是对药物治疗不再有反应的患者的一种有效的辅助治疗方法。Ebling分级是一个实用且可靠的参数,有助于更好地评估MAGA和FAGA患者。